Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iDEAt2: Insulin Detemir vs NPH in Pediatric T2D
NCT02131272Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 24
01
Overview
A Phase 3 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2014; status: terminated.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02131272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131272.